IRF5 and thyroid gland carcinoma: We found that IRF5 over-expression conferred a proliferative advantage to three of four thyroid cell lines (SW1736, WRO, and C643) suggesting a role for IRF5 in promoting thyroid cancer growth (Figure 3B).